These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 18980970)
1. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage. Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970 [TBL] [Abstract][Full Text] [Related]
2. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419 [TBL] [Abstract][Full Text] [Related]
3. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells. Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075 [TBL] [Abstract][Full Text] [Related]
4. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma. Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277 [TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579 [TBL] [Abstract][Full Text] [Related]
7. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function. Smith M; Tourigny MR; Noakes P; Thornton CA; Tulic MK; Prescott SL J Allergy Clin Immunol; 2008 Jun; 121(6):1460-6, 1466.e1-7. PubMed ID: 18455222 [TBL] [Abstract][Full Text] [Related]
8. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role? Förger F; Villiger PM; Ostensen M Arthritis Rheum; 2009 Feb; 61(2):279-83. PubMed ID: 19177540 [TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells. Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation. Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785 [TBL] [Abstract][Full Text] [Related]
13. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058 [TBL] [Abstract][Full Text] [Related]
14. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy. Zhang L; Dermawan K; Jin M; Liu R; Zheng H; Xu L; Zhang Y; Cai Y; Chu Y; Xiong S Clin Immunol; 2008 Nov; 129(2):219-29. PubMed ID: 18771959 [TBL] [Abstract][Full Text] [Related]
15. Increase of regulatory T cells in the peripheral blood of cancer patients. Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425 [TBL] [Abstract][Full Text] [Related]
16. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. Igarashi H; Cao Y; Iwai H; Piao J; Kamimura Y; Hashiguchi M; Amagasa T; Azuma M Biochem Biophys Res Commun; 2008 May; 369(4):1134-8. PubMed ID: 18346459 [TBL] [Abstract][Full Text] [Related]
17. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma. Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318 [TBL] [Abstract][Full Text] [Related]
18. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes. Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796 [TBL] [Abstract][Full Text] [Related]
19. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome. Li Q; Wang Y; Chen K; Zhou Q; Wei W; Wang Y; Wang Y Biochem Biophys Res Commun; 2010 Apr; 394(3):836-42. PubMed ID: 20302843 [TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer. Masuno T; Ikeda T; Yokota S; Komuta K; Ogura T; Kishimoto S Cancer Res; 1986 Aug; 46(8):4195-9. PubMed ID: 3015385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]